Eris Lifesciences to buy some dermatology brands from Glenmark Pharma

The deal for the portfolio that has an annual revenue base of 850 million rupees, will be financed through borrowings, and the transaction is expected to achieve financial closure very soon, Eris said

from Latest Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/YGI4cAF
https://ift.tt/K4iXf1o

Post a Comment

Previous Post Next Post